Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Agilon Health (AGL) Short term Debt (2020 - 2025)

Agilon Health (AGL) has disclosed Short term Debt for 6 consecutive years, with $19.2 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Short term Debt changed N/A year-over-year to $19.2 million, compared with a TTM value of $19.2 million through Dec 2025, changed N/A, and an annual FY2025 reading of $19.2 million, changed N/A over the prior year.
  • Short term Debt was $19.2 million for Q4 2025 at Agilon Health, down from $35.0 million in the prior quarter.
  • Across five years, Short term Debt topped out at $35.0 million in Q3 2025 and bottomed at $3.8 million in Q2 2021.
  • Average Short term Debt over 5 years is $11.5 million, with a median of $5.0 million recorded in 2021.
  • The sharpest move saw Short term Debt changed 0.0% in 2022, then soared 365.65% in 2025.
  • Year by year, Short term Debt stood at $5.0 million in 2021, then changed by 0.0% to $5.0 million in 2022, then increased by 25.0% to $6.2 million in 2023, then soared by 40.0% to $8.8 million in 2024, then skyrocketed by 119.86% to $19.2 million in 2025.
  • Business Quant data shows Short term Debt for AGL at $19.2 million in Q4 2025, $35.0 million in Q3 2025, and $34.9 million in Q2 2025.